Roth Capital started coverage on shares of Neogen (NASDAQ:NEOG) in a research note published on Tuesday. The brokerage issued a neutral rating and a $82.00 price objective on the stock.

NEOG has been the topic of a number of other research reports. Zacks Investment Research cut shares of Neogen from a buy rating to a hold rating in a research note on Friday, August 18th. BidaskClub raised shares of Neogen from a hold rating to a buy rating in a research note on Thursday, August 10th.

Shares of Neogen (NASDAQ:NEOG) traded down $1.87 during trading hours on Tuesday, reaching $81.59. 92,500 shares of the company were exchanged, compared to its average volume of 110,844. The company has a market capitalization of $3,188.33, a PE ratio of 70.13, a price-to-earnings-growth ratio of 4.25 and a beta of 1.54. Neogen has a fifty-two week low of $59.51 and a fifty-two week high of $85.89.

Neogen (NASDAQ:NEOG) last announced its quarterly earnings data on Tuesday, September 19th. The company reported $0.31 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.30 by $0.01. The business had revenue of $95.30 million for the quarter, compared to analysts’ expectations of $94.87 million. Neogen had a net margin of 12.28% and a return on equity of 9.93%. The firm’s quarterly revenue was up 14.0% compared to the same quarter last year. During the same period last year, the firm posted $0.26 earnings per share. research analysts forecast that Neogen will post 1.31 EPS for the current fiscal year.

In other news, VP Edward Bradley sold 17,824 shares of Neogen stock in a transaction on Friday, November 17th. The shares were sold at an average price of $80.32, for a total transaction of $1,431,623.68. Following the transaction, the vice president now owns 27,212 shares in the company, valued at $2,185,667.84. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, insider James L. Herbert sold 26,000 shares of Neogen stock in a transaction on Monday, November 13th. The stock was sold at an average price of $81.45, for a total transaction of $2,117,700.00. Following the transaction, the insider now owns 879,430 shares in the company, valued at approximately $71,629,573.50. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 186,662 shares of company stock worth $14,271,286. Insiders own 4.20% of the company’s stock.

Hedge funds have recently added to or reduced their stakes in the stock. Teacher Retirement System of Texas acquired a new position in Neogen in the second quarter valued at $209,000. State Street Corp raised its holdings in shares of Neogen by 4.8% during the second quarter. State Street Corp now owns 949,434 shares of the company’s stock valued at $65,613,000 after purchasing an additional 43,496 shares during the period. Fairfield Bush & CO. raised its holdings in shares of Neogen by 4.6% during the second quarter. Fairfield Bush & CO. now owns 86,570 shares of the company’s stock valued at $5,983,000 after purchasing an additional 3,845 shares during the period. BNP Paribas Arbitrage SA raised its holdings in shares of Neogen by 56.0% during the second quarter. BNP Paribas Arbitrage SA now owns 12,414 shares of the company’s stock valued at $858,000 after purchasing an additional 4,455 shares during the period. Finally, Russell Investments Group Ltd. raised its holdings in shares of Neogen by 55.7% during the second quarter. Russell Investments Group Ltd. now owns 32,533 shares of the company’s stock valued at $2,249,000 after purchasing an additional 11,638 shares during the period. Institutional investors and hedge funds own 87.06% of the company’s stock.

TRADEMARK VIOLATION NOTICE: “Neogen (NEOG) Receives New Coverage from Analysts at Roth Capital” was originally reported by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are reading this report on another publication, it was stolen and reposted in violation of United States and international copyright and trademark laws. The correct version of this report can be viewed at https://www.thecerbatgem.com/2017/12/06/neogen-neog-receives-new-coverage-from-analysts-at-roth-capital.html.

About Neogen

Neogen Corporation develops, manufactures and markets a range of products and services dedicated to food and animal safety. The Company operates through two segments: Food Safety and Animal Safety. The Food Safety segment produces and markets diagnostic test kits and related products used by food producers and processors to detect harmful natural toxins, foodborne bacteria, allergens and levels of general sanitation.

Receive News & Stock Ratings for Neogen Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Neogen Corporation and related stocks with our FREE daily email newsletter.